September 2006 Issue of MMM
While I didn't need another reason for chalking up 1966 as a vintage year, I quickly found one when I joined Medical Marketing & Media: ...
The demand for talent, apparent at virtually every level and sector, appears to be the driver for a modest hike in salaries for medical marketing ...
Complaining about a shortage of talent is all well and good, but it won't fill all those vacant positions. So what are agencies actually doing ...
Reps and product managers are getting a helping hand as they climb the corporate ladder in pharma. Companies that invest in staff development reap long-term ...
A bachelor's degree and a little experience used to be enough to land a job in healthcare marketing. But now employers are looking for PhDs, ...
Marjorie Martin is, by her own admission, "kind of a geek" about medicine.
When the New England Journal of Medicine reported last month on the 2005 measles outbreak, it did us all a favor.
When Pfizer's board named a legal eagle and former McDonald's man to steer the sputtering behemoth through rocky shoals, they voted first for change.
Med Ed Report
Pharmaceutical company support for CME increased 4% in 2005 to $1.1 billion, but higher expenses swallowed up any profit for publishing and education companies, according ...
Mobile medical information company Skyscape has launched a CME offering based on the point-of-care model of CME.
Thomson Medical Education (TME), whose three businesses comprise the world's largest med ed organization,will be sold.
Jobson Medical Information (JMI) has formed Postgraduate Healthcare Education (PHE), an accredited CME provider, to be headed by Chris Colatriano.
Intellyst Medical has hired Doug Pousma, MD, MBA as SVP, director of CME.
Judith McHale, president/CEO of Discovery Communications is resigning Dec. 1.
The Society for Academic CME is exploring formal collaboration with the ACCME and the AMA to investigate alternative models of CME accreditation that focus attention ...
The Postgraduate Institute for Medicine (PIM) has hired Jan Schultz, RN, MSN, as director of educational outcomes and accreditation to lead PIM's new outcomes measurement ...
Medizine is launching a series of 10 point-of-care consumer specialty magazines, each with an online counterpart, and recently named AOL Health head Carla Wojnaroski to ...
Kevin King, president and CEO of Thomson Healthcare, has left the company.
Lippincott Williams & Wilkins launched Advanced Emergency Nursing Journal, with a July/September issue publishing in August.
Advanstar reported first-half revenues up 13% year-on-year, from $146 million to $165 million--though its life sciences division was nearly flat for Q2.
JAMA editor-in-chief Catherine DeAngelis said she was duped by study authors who failed to disclose ties to drug companies.
Quadrant HealthCom is launching Urgent Care, the official journal of the American Academy of Urgent Care Medicine (AAUCM).
Healthcare agencies have seen something of an exodus of media planning and buying professionals in recent years.
Television as an advertising medium is losing its edge.
E-marketing veteran Meg Columbia-Walsh has joined WPP-held CommonHealth as managing partner and president.
WebMD Health has acquired the interactive medical businesses of Medsite for $41 million in cash.
WPP's Grey has brought all its direct marketing, branding and design interactive services under a new global brand umbrella, G2 Direct and Digital, or G2D2.
Neurocrine Biosciences has laid off its entire 200-person sales force, the San Diego firm said.
Publicis Healthcare Communications Group, a division of Paris-based Publicis Groupe, announced the creation of Halo, an advertising agency specializing in interactive and relationship marketing.
Anthony Marucci, Jr. has joined Patient Marketing Group (PMG) as director, account management.
Grey Healthcare Group has acquired Boston-based online advertising and marketing firm Catalyst.
Patient/physician communication programs provider InfoMedics, has hired Robert Bedford as SVP of sales and client relations.
Harte-Hanks has launched a new physician marketing solution.
One year after the launch of Rozerem, Takeda rolled out a DTC campaign aimed at unmedicated insomnia sufferers, advising that "Your dreams miss you."
The FDA slapped Eli Lilly with a warning letter over a patient brochure for its oncology treatment Alimta, saying the mailer glossed over the drug's ...
Merck is launching a Spanish-language version of its consumer title Your Health Now.
Johnson & Johnson's McNeil Consumer & Specialty Pharmaceuticals launched a $30 million campaign for chewable Tylenol, targeting a younger-than-usual audience: 30- and 40-somethings with kids.
Sepracor president William O'Shea told analysts and investors that Lunesta's share of the sleep-aid market is nearing 40%, thanks to the company's aggressive direct-to-patient promotional ...
The law of unintended consequences is doing great harm to healthcare associations and advocacy groups, as companies have been forced to retreat from traditional venues ...
Schering-Plough named Pfizer's Catherine Cantone director, global product communications and advocacy relations.
Healthcare CEOs are concerned about corporate reputation, according to a survey by FischerHealth, Porter Novelli Consulting and PRSA Health Academy.
At the FDA-industry interface, how close is too close?
Bad news for authorized generics on two fronts.
Proposed drug safety legislation would require each new drug and biologic approved by the FDA to have a Risk Evaluation and Mitigation Strategy (REMS).
The FDA promised to address with all seriousness a survey of its scientists which reported poor morale and "pervasive and dangerous political influence of science ...
Finance Committee chairman Sen. Chuck Grassley (R-IA) has asked the HHS inspector general to find out how an FDA employee worked "in concert with a ...
The Center for Reproductive Rights asked a federal judge for permission to request e-mails, letters and records of conversations between the FDA and the White ...
FDA drug safety expert, whistleblower Dr. David Graham, has called on FDA officials to pull from the market Sanofi-Aventis' controversial antibiotic Ketek, saying it is ...
A Senate-approved amendment to a Homeland Security Department FY2007 spending bill would allow drugs to be imported into the US by citizens returning from Canada.
The Zovirax (acyclovir) ointment Web site, along with a consumer STD awareness deck card, misleadingly suggest to consumers that the GlaxoSmithKline product may prevent transmission ...
He had a way with words. Anyone who knew him would tell you that.
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.